Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 13 Jun 2024 11:42 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA - Bridge financing requested from Atlas | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Jun 2024 08:06 CEST |
CIRCIO HOLDING ASA | Atlas Holdings for CIRCIO | 20103010 Biotechnology | Major shareholding notifications |
| 10 Jun 2024 08:16 CEST |
CIRCIO HOLDING ASA | Atlas Holdings for CIRCIO | 20103010 Biotechnology | Major shareholding notifications |
| 07 Jun 2024 08:24 CEST |
CIRCIO HOLDING ASA | Atlas Holdings for CIRCIO | 20103010 Biotechnology | Major shareholding notifications |
| 06 Jun 2024 13:00 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA: Registration of share capital increase following conversions of convertible bonds and change of the ratio of subscription rights in the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Jun 2024 12:38 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 20103010 Biotechnology | Total number of voting rights and capital |
| 04 Jun 2024 21:44 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 20103010 Biotechnology | Total number of voting rights and capital |
| 03 Jun 2024 09:14 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA: Requested Conversion of Convertible Bonds | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 31 May 2024 08:29 CEST |
CIRCIO HOLDING ASA | Atlas Holdings for CIRCIO | 20103010 Biotechnology | Major shareholding notifications |
| 30 May 2024 15:52 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA: Requested Conversion of Convertible Bonds | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 May 2024 15:33 CEST |
CIRCIO HOLDING ASA | Notification of major holdings | 20103010 Biotechnology | Major shareholding notifications |
| 29 May 2024 16:42 CEST |
CIRCIO HOLDING ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 May 2024 16:00 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA - Key information relating to the rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 May 2024 15:50 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA - Notice of annual general meeting 2024 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 May 2024 07:00 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA - Terms of the rights issue and related transactions | 20103010 Biotechnology | Inside information |
| 29 May 2024 07:00 CEST |
CIRCIO HOLDING ASA | Circio announces financing that secures cash runway for twelve months | 20103010 Biotechnology | Inside information |
| 13 May 2024 07:00 CEST |
CIRCIO HOLDING ASA | Circio presents pre-clinical proof-of-concept data for its circVec gene therapy platform at the ASGCT 2024 meeting | 20103010 Biotechnology | Non-regulatory press releases |
| 29 Apr 2024 09:37 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 20103010 Biotechnology | Total number of voting rights and capital |
| 25 Apr 2024 23:49 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA: Annual Report 2023 | 20103010 Biotechnology | Annual financial and audit Reports |
| 25 Apr 2024 13:55 CEST |
CIRCIO HOLDING ASA | Circio Holding ASA: Requested Conversion of Convertible Bonds | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Apr 2024 08:00 CEST |
CIRCIO HOLDING ASA | Circio announces in vivo proof-of-concept for its circVec circular RNA platform technology and reinforced gene therapy focus | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Apr 2024 07:55 CEST |
CIRCIO HOLDING ASA | Circio announces intention to raise around NOK 50-60 million in Q2 2024 to extend cash runway to Q2 2025 | 20103010 Biotechnology | Inside information |
| 17 Apr 2024 07:50 CEST |
CIRCIO HOLDING ASA | Circio terminates TG01 cancer vaccine license option agreement with IOVaxis in China for non-payment | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Apr 2024 07:00 CEST |
CIRCIO HOLDING ASA | Circio invites to a company update on Wednesday 17 April 2024 | 20103010 Biotechnology | Non-regulatory press releases |
| 27 Mar 2024 11:08 CET |
CIRCIO HOLDING ASA | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 20103010 Biotechnology | Total number of voting rights and capital |
| 21 Mar 2024 12:45 CET |
CIRCIO HOLDING ASA | Circio Holding ASA: Requested Conversion of Convertible Bonds | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 Mar 2024 12:43 CET |
CIRCIO HOLDING ASA | Circio announces that partner IOVaxis Therapeutics has exercised the option for an exclusive license to mutant RAS cancer vaccine TG01 in China | 20103010 Biotechnology | Inside information |
| 13 Mar 2024 09:42 CET |
CIRCIO HOLDING ASA | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 20103010 Biotechnology | Total number of voting rights and capital |
| 08 Mar 2024 13:52 CET |
CIRCIO HOLDING ASA | Circio Holding ASA: Approval and publication of prospectus | 20103010 Biotechnology | Prospectus / admission document |
| 05 Mar 2024 08:27 CET |
CIRCIO HOLDING ASA | Circio Holding ASA: Requested Conversion of Convertible Bonds | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Mar 2024 16:31 CET |
CIRCIO HOLDING ASA | The TG01 IND application by Circio's partner IOVaxis Therapeutics has been approved by the Chinese regulatory authorities | 20103010 Biotechnology | Non-regulatory press releases |
| 04 Mar 2024 12:51 CET |
CIRCIO HOLDING ASA | Circio Holding ASA: Requested Conversion of Convertible Bonds | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Feb 2024 07:00 CET |
CIRCIO HOLDING ASA | Circio to participate in the Annual European Life Sciences CEO Forum in Zürich | 20103010 Biotechnology | Non-regulatory press releases |
| 07 Feb 2024 11:07 CET |
CIRCIO HOLDING ASA | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 20103010 Biotechnology | Total number of voting rights and capital |
| 05 Feb 2024 09:49 CET |
CIRCIO HOLDING ASA | Circio Holding ASA: Requested Conversion of Convertible Bonds | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 01 Feb 2024 07:00 CET |
CIRCIO HOLDING ASA | The first patient has been dosed in Circio's TG01 triple combination study | 20103010 Biotechnology | Non-regulatory press releases |
| 22 Jan 2024 07:00 CET |
CIRCIO HOLDING ASA | Circio to present at upcoming conferences | 20103010 Biotechnology | Non-regulatory press releases |
| 18 Jan 2024 07:54 CET |
CIRCIO HOLDING ASA | Circio receives waiver of EUR 6.2 million in loans from Business Finland | 20103010 Biotechnology | Inside information |
| 12 Jan 2024 10:03 CET |
CIRCIO HOLDING ASA | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 20103010 Biotechnology | Total number of voting rights and capital |
| 10 Jan 2024 14:41 CET |
CIRCIO HOLDING ASA | Circio Holding ASA: Requested Conversion of Convertible Bonds | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Jan 2024 10:06 CET |
CIRCIO HOLDING ASA | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 20103010 Biotechnology | Total number of voting rights and capital |
| 28 Dec 2023 15:24 CET |
CIRCIO HOLDING ASA | Circio Holding ASA: Requested Conversion of Convertible Bonds | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Dec 2023 16:48 CET |
CIRCIO HOLDING ASA | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 20103010 Biotechnology | Total number of voting rights and capital |
| 19 Dec 2023 13:47 CET |
CIRCIO HOLDING ASA | Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds | 20103010 Biotechnology | Total number of voting rights and capital |
| 18 Dec 2023 10:35 CET |
CIRCIO HOLDING ASA | Circio Holding ASA: Requested Conversion of Convertible Bonds | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Dec 2023 12:24 CET |
CIRCIO HOLDING ASA | Circio Holding ASA: Requested Conversion of Convertible Bonds | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Dec 2023 08:06 CET |
CIRCIO HOLDING ASA | Finansiell kalender | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 13 Dec 2023 08:06 CET |
CIRCIO HOLDING ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 12 Dec 2023 07:32 CET |
CIRCIO HOLDING ASA | TG01 IND application filed in China by Circio's partner IOVaxis Therapeutics | 20103010 Biotechnology | Non-regulatory press releases |
| 07 Dec 2023 07:00 CET |
CIRCIO HOLDING ASA | Circio announces completion of planned safety review and opening for full enrollment of TG01 study at Oslo University Hospital | 20103010 Biotechnology | Non-regulatory press releases |